Briefing

Industry news

Industry briefing

Covid-19 briefing

NEWS

FDA approves Gilead’s Veklury for Covid-19 in paediatric patients

BRIEFING

Glyscend concludes Phase I trial of oral type 2 diabetes therapy

In the trial, GLY-200 was found to be well-tolerated across all tested dose levels without any safety signals detected.

covid-19

Covid-19 vaccines and strong capital markets still drive Pharma growth

According to an ongoing GlobalData poll, the biggest impact of the Covid-19 pandemic has been in supply chain.

Industry news

Industry briefing

Covid-19 briefing

06/01/2022 13:47:59
  • Home | Continuous manufacturing cautiously builds on hype
  • In this issue
  • CSafe Global
  • Contents
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • SHL Medical Company Insight
  • SHL Medical
  • WR Grace
  • Comment
  • CMO agreements need to go public, but ‘glib’ onshoring not the answer
  • Biologic sales forecast to pass innovative small molecule sales in next five yea
  • The telemedicine community has rallied to provide support to patients in Ukraine
  • Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments
  • BioLife Solutions
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • Continuous manufacturing builds on hype but adoption remains gradual
  • Can Relmada’s fast-acting pill for major depressive disorder compete in
  • Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compa
  • How ambitious are the emissions targets of pharma and biotech companies?
  • Should Covid-19 clinical trial plans still centre around EUAs?
  • BEA Technologies
  • Datwyler Company Insight
  • Datwyler
  • In Data
  • Top and emerging locations for M&A deals in the pharma industry
  • Deals relating to genomics increased in the pharma industry in H2 2021
  • Pharma industry companies are increasingly innovating in machine learning
  • Baxter
  • Events
  • Next issue